Peyton Howell is Chief Operating and Growth Officer at Parexel. She joined Parexel in 2018 and most recently was President, Consulting and Chief Commercial & Strategy Officer leading the company to record new business growth and creation of a patient-focused strategy.
She has more than 25 years of leadership experience in the healthcare industry and prior to joining Parexel held several leadership positions with AmerisourceBergen — now Cencora (a Fortune 20 company) — most recently as President for Health Systems and Specialty Care Solutions, a $50B business unit. Ms. Howell was a founder of Lash Group, growing the company from an early innovator of patient access services to nearly 5,000 employees and serving as President for nearly 10 years following its acquisition by AmerisourceBergen.
She holds a Masters’ in Healthcare Administration (MHA) from The Ohio State University and in 2020 was named a Luminary by the Healthcare Businesswomen’s Association (HBA). Ms. Howell serves on the Board of Directors of Tandem Diabetes Care (NASDQ: TNDM), a medical device manufacturer, and has represented Parexel on the ACRO Board since 2020.
